10-Q quarterly report · filed Nov 4, 2026

STAAR SURGICAL CO (STAA) Q4 2026 10-Q Quarterly Report

Short answer

STAAR SURGICAL CO (STAA) filed its Q4 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Oct 2, 2026. Quarterly revenue was $83M (down 12.0% year over year) with net income of $6M.

Q4 2026 key financials · XBRL

Revenue
$83M
−12.0% YoY · −10.8% QoQ
Net income
$6M
−37.2% YoY · −30.8% QoQ
Operating margin
6.5%
Gross margin
70.9%
EPS (diluted)
$0.11
−38.9% YoY · −31.3% QoQ

Source: XBRL data from the STAAR SURGICAL CO (STAA) Q4 2026 10-Q on SEC EDGAR. USD.

STAAR SURGICAL CO Q4 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $83.4M, down 12% YoY, or up 21.1% excluding $25.9M December China Shipment
  • Gross margin 70.9% vs 82.2% YoY, pressured by ERP-related costs, freight, tariffs and inventory provisions
  • EMEA best-performing region, sales up 31%; APAC weakest, sales down 20% from China shipment effects
  • Cash and investments $206.4M, up from $181.5M sequentially; nine-month operating cash flow $25.3M vs $(30.3)M
  • 2026 gross-margin target of 75% not expected; fourth-quarter improvement anticipated, with ERP and tariff headwinds persisting

Risk Factors

  • No material changes disclosed from the January 2, 2026 Form 10-K
  • Carried-forward risk: External factors could materially adversely affect business, financial condition, or operating results
  • No new regulatory, operational, competitive, or financial risks identified in the quarter

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other STAAR SURGICAL CO quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.